These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17717190)

  • 1. Cellular protection by erythropoietin: new therapeutic implications?
    Joyeux-Faure M
    J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and myocardial protection: what's new?
    Joyeux-Faure M; Godin-Ribuot D; Ribuot C
    Fundam Clin Pharmacol; 2005 Aug; 19(4):439-46. PubMed ID: 16011730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
    Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
    J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat.
    Sepodes B; Maio R; Pinto R; Sharples E; Oliveira P; McDonald M; Yaqoob M; Thiemermann C; Mota-Filipe H
    Transpl Int; 2006 Nov; 19(11):919-26. PubMed ID: 17018128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors.
    Brines M
    Blood Purif; 2010; 29(2):86-92. PubMed ID: 20093809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin is a multifunctional tissue-protective cytokine.
    Erbayraktar S; Yilmaz O; Gökmen N; Brines M
    Curr Hematol Rep; 2003 Nov; 2(6):465-70. PubMed ID: 14561390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin in the brain: can the promise to protect be fulfilled?
    Maiese K; Li F; Chong ZZ
    Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin--a new therapy in cerebral ischemia?].
    Kalialis LV; Olsen NV
    Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin biology in cancer.
    Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
    Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
    Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH
    J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin in cardiac disease: new features of an old drug.
    Ruifrok WP; de Boer RA; Westenbrink BD; van Veldhuisen DJ; van Gilst WH
    Eur J Pharmacol; 2008 May; 585(2-3):270-7. PubMed ID: 18407263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of erythropoietin in neuroprotection: therapeutic perspectives.
    Grasso G; Sfacteria A; Meli F; Passalacqua M; Fodale V; Buemi M; Giambartino F; Iacopino DG; Tomasello F
    Drug News Perspect; 2007 Jun; 20(5):315-20. PubMed ID: 17878959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin in cancer: the new face of an old friend.
    Megalakaki C
    J BUON; 2008; 13(1):7-16. PubMed ID: 18404780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
    Fliser D; Haller H
    Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating erythropoiesis: future perspectives.
    Mikhail A; Covic A; Goldsmith D
    Kidney Blood Press Res; 2008; 31(4):234-46. PubMed ID: 18587242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis stimulation in acute ischemic syndromes.
    Ruifrok WP; Lipsic E; de Boer RA; van Gilst WH; van Veldhuisen DJ
    Heart Fail Clin; 2010 Jul; 6(3):313-21. PubMed ID: 20630406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin in stroke: quo vadis.
    Digicaylioglu M
    Expert Opin Biol Ther; 2010 Jun; 10(6):937-49. PubMed ID: 20394473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.